Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Bullboard Posts
Comment by davikingon Aug 09, 2017 12:22pm
126 Views
Post# 26561367

RE:RE:RE:RE:Published effacacy of 11 to 12% in November of 2014

RE:RE:RE:RE:Published effacacy of 11 to 12% in November of 2014Thanks, MM, you prove my point about you being SWYG et al. Same writing style (over and over). Talk about the "pot calling the kettle black".  Good post!! NOT!
Optiongrinder, thanks for you contribution. I see the process being valid but .. yah, I won't belabour my point. Lots of people dying/suffering with after effects of sepsis while we await final approval with prior knowledge of what works.

Bullboard Posts